ICL Group Ltd.

STAAR Surgical Celebrates 30th Anniversary of Implantable Collamer® Lens (ICL)

Retrieved on: 
Tuesday, October 17, 2023

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, is celebrating the 30th anniversary of its proprietary Implantable Collamer® Lens (ICL).

Key Points: 
  • STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, is celebrating the 30th anniversary of its proprietary Implantable Collamer® Lens (ICL).
  • The early ICLs have evolved into the current generation of ICLs with a central port – the EVO ICL™ family of lenses.
  • “We celebrate the 30th anniversary of our ICL technology with surgeons and patients,” said Tom Frinzi, President and CEO of STAAR Surgical.
  • 1 Packer M. The Implantable Collamer Lens with a central port: review of the literature.

Adicon Holdings Limited (9860.HK): Continuous growth in Core Operations, Consistent Profitability Enhancement

Retrieved on: 
Friday, September 1, 2023

For the six months ended June 30, 2023, the Company's core business experienced substantial growth, resulting in total operating revenue of RMB1.644 billion.

Key Points: 
  • For the six months ended June 30, 2023, the Company's core business experienced substantial growth, resulting in total operating revenue of RMB1.644 billion.
  • Its traditional base testing business rebounded with a 33% year-on-year increase in revenue, while its esoteric testing business witnessed 48% growth.
  • During the reporting period, Adicon achieved a gross profit margin of 43.6%, an increase of 3.2 percentage points over the prior year.
  • In addition, Adicon has remained committed to introducing novel testing technologies, with esoteric testing services driving a second wave of growth.

ICL to Participate in Fireside Chat at Jefferies 2023 Industrials Conference

Retrieved on: 
Wednesday, August 30, 2023

ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today announced Phil Brown, president of the company’s Phosphate Division and managing director of North America for ICL, will be presenting at Jefferies 2023 Industrials Conference at 4 p.m.

Key Points: 
  • ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today announced Phil Brown, president of the company’s Phosphate Division and managing director of North America for ICL, will be presenting at Jefferies 2023 Industrials Conference at 4 p.m.
  • A replay will be available at the same site for a limited time, following the live event.
  • ICL Group is a leading global specialty minerals company, which creates impactful solutions for humanity's sustainability challenges in the food, agriculture and industrial markets.
  • ICL shares are dual listed on the New York Stock Exchange and the Tel Aviv Stock Exchange (NYSE and TASE: ICL).

Potash Emerges as an Important Component for Global Food Production

Retrieved on: 
Tuesday, August 15, 2023

NEW YORK, Aug. 15, 2023 /PRNewswire/ -- Potash is used in a wide variety of areas and most commonly refers to a group of potassium-rich minerals and chemicals. It is the vital ingredient to produce fertilizer and is widely used in the agricultural industry to boost crop yields and support plant growth. The most common type of potash is Muriate of Potash (MOP) derived from potassium chloride (KCI). It accounts for approximately 95% of the global agricultural potash. Potash also helps to improve the quality of crops by enhancing their flavor, color, and texture. As a result, the market value projections for potash are positive, with the global demand for potash expected to increase due to the growing population and the need for increased food production. Overall, according to data published by the Business Research Company, the global potash market size will grow from USD 22.04 Billion in 2022 to USD 23.03 Billion in 2023, while at a compound annual growth rate (CAGR) of 4.5%. Sage Potash Corp. (TSX-V: SAGE), The Mosaic Company (NYSE: MOS), Intrepid Potash, Inc. (NYSE: IPI), Nutrien Ltd. (NYSE: NTR), ICL Group Ltd. (NYSE: ICL)

Key Points: 
  • The most common type of potash is Muriate of Potash (MOP) derived from potassium chloride (KCI).
  • As a result, the market value projections for potash are positive, with the global demand for potash expected to increase due to the growing population and the need for increased food production.
  • "The disruption at the Port of Vancouver has resulted in the curtailment of production at our Cory potash mine and if prolonged could also impact production at our other potash mines in Saskatchewan.
  • ICL Group is a leading global specialty minerals company, which creates impactful solutions for humanity's sustainability challenges in the food, agriculture and industrial markets.

Potash Emerges as an Important Component for Global Food Production

Retrieved on: 
Tuesday, August 15, 2023

NEW YORK, Aug. 15, 2023 /PRNewswire/ -- Potash is used in a wide variety of areas and most commonly refers to a group of potassium-rich minerals and chemicals. It is the vital ingredient to produce fertilizer and is widely used in the agricultural industry to boost crop yields and support plant growth. The most common type of potash is Muriate of Potash (MOP) derived from potassium chloride (KCI). It accounts for approximately 95% of the global agricultural potash. Potash also helps to improve the quality of crops by enhancing their flavor, color, and texture. As a result, the market value projections for potash are positive, with the global demand for potash expected to increase due to the growing population and the need for increased food production. Overall, according to data published by the Business Research Company, the global potash market size will grow from USD 22.04 Billion in 2022 to USD 23.03 Billion in 2023, while at a compound annual growth rate (CAGR) of 4.5%. Sage Potash Corp. (TSX-V: SAGE), The Mosaic Company (NYSE: MOS), Intrepid Potash, Inc. (NYSE: IPI), Nutrien Ltd. (NYSE: NTR), ICL Group Ltd. (NYSE: ICL)

Key Points: 
  • The most common type of potash is Muriate of Potash (MOP) derived from potassium chloride (KCI).
  • As a result, the market value projections for potash are positive, with the global demand for potash expected to increase due to the growing population and the need for increased food production.
  • "The disruption at the Port of Vancouver has resulted in the curtailment of production at our Cory potash mine and if prolonged could also impact production at our other potash mines in Saskatchewan.
  • ICL Group is a leading global specialty minerals company, which creates impactful solutions for humanity's sustainability challenges in the food, agriculture and industrial markets.

ICL Breaks Ground on $400 Million Battery Materials Manufacturing Plant in St. Louis

Retrieved on: 
Wednesday, August 9, 2023

ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, celebrated the groundbreaking of its battery materials manufacturing plant in St. Louis, which is expected to be the first large-scale lithium iron phosphate (LFP) facility in the U.S.

Key Points: 
  • ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, celebrated the groundbreaking of its battery materials manufacturing plant in St. Louis, which is expected to be the first large-scale lithium iron phosphate (LFP) facility in the U.S.
  • ICL’s investment in the plant was augmented by a $197 million grant from the U.S. Department of Energy.
  • The $400 million dollar plant will manufacture materials for lithium iron phosphate batteries and will be the first large-scale facility of its kind in the United States.
  • Also pictured are (left) Phil Brown, president of Phosphate Specialties Solutions at ICL Group and (right) Raviv Zoller, president and CEO of ICL.

STAAR Surgical Reports Second Quarter 2023 Results

Retrieved on: 
Wednesday, August 2, 2023

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today reported financial results for the second quarter ended June 30, 2023.

Key Points: 
  • STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today reported financial results for the second quarter ended June 30, 2023.
  • Net sales were $92.3 million for the second quarter of 2023, up 14% compared to $81.1 million reported in the prior year quarter.
  • Gross profit margin for the second quarter of 2023 was 76.6% compared to the prior year quarter of 78.8%.
  • Operating expenses for the second quarter of 2023 were $62.1 million compared to the prior year quarter of $46.9 million.

ZYUS Life Sciences Strengthens Board of Directors with the Appointment of Wayne Brownlee

Retrieved on: 
Thursday, June 29, 2023

ZYUS Life Sciences Corp. ("ZYUS" or the “Company”) (TSX-V: ZYUS), a Canadian-based life sciences company leading scientific research and global development of innovative cannabinoid-based pharmaceutical drug products, is pleased to announce that Wayne Brownlee, former Vice-President and Chief Financial Officer (“CFO”) of both Potash Corporation of Saskatchewan Inc. (“PotashCorp”) and Nutrien Ltd. (“Nutrien”), has agreed to accept an appointment to ZYUS’ Board of Directors.

Key Points: 
  • ZYUS Life Sciences Corp. ("ZYUS" or the “Company”) (TSX-V: ZYUS), a Canadian-based life sciences company leading scientific research and global development of innovative cannabinoid-based pharmaceutical drug products, is pleased to announce that Wayne Brownlee, former Vice-President and Chief Financial Officer (“CFO”) of both Potash Corporation of Saskatchewan Inc. (“PotashCorp”) and Nutrien Ltd. (“Nutrien”), has agreed to accept an appointment to ZYUS’ Board of Directors.
  • Mr. Brownlee brings a wealth of knowledge, experience and expertise to his new role with ZYUS.
  • In 1989, Mr. Brownlee joined PotashCorp when it was a Crown corporation and was a catalyst for the expansion and development throughout its acquisition activity.
  • “We are extremely pleased to welcome Wayne Brownlee to ZYUS’ Board of Directors,” said Brent Zettl, President and Chief Executive Officer of the Company.

Kamada Announces Chief Financial Officer Chaime Orlev to Remain in Role and Appointment of Nir Livneh as Vice President, General Counsel and Corporate Secretary

Retrieved on: 
Wednesday, May 24, 2023

Separately, the Company also announced that Nir Livneh, who previously served as its General Counsel and Corporate Secretary, from 2010-2018, has rejoined Kamada as Vice President, General Counsel and Corporate Secretary, reporting to the Company's Chief Executive Officer, Amir London.

Key Points: 
  • Separately, the Company also announced that Nir Livneh, who previously served as its General Counsel and Corporate Secretary, from 2010-2018, has rejoined Kamada as Vice President, General Counsel and Corporate Secretary, reporting to the Company's Chief Executive Officer, Amir London.
  • Prior to rejoining Kamada, Mr. Livneh served as Vice President of Legal Affairs at Purple Biotech Ltd.
  • Previously, he was Legal Counsel at ICL Group Ltd. and General Counsel of PolyPid Ltd. Mr. Livneh holds an LL.B in Law and a B.A.
  • We are also excited to welcome back Nir as our Vice President, General Counsel and Corporate Secretary.

ICL Signs a Sustainability-Linked Revolving Credit Facility with a Syndicate of Banks

Retrieved on: 
Monday, April 24, 2023

ICL hereby announces, that on April 20, 2023, it entered into a Sustainability-Linked Revolving Credit Facility Agreement made between its subsidiary ICL Finance B.V., as borrower, and a consortium of twelve (12) international banks (the "Lenders") for $1,550 million, guaranteed by ICL (the "Sustainability-Linked RCF" or the “New RCF”).

Key Points: 
  • ICL hereby announces, that on April 20, 2023, it entered into a Sustainability-Linked Revolving Credit Facility Agreement made between its subsidiary ICL Finance B.V., as borrower, and a consortium of twelve (12) international banks (the "Lenders") for $1,550 million, guaranteed by ICL (the "Sustainability-Linked RCF" or the “New RCF”).
  • For details regarding the Previous RCF, see company’s immediate report dated March 24, 2015 (Ref No: 2015-02-059557).
  • For details regarding ICL’s credit from banks, and its underlying financial covenants, see Note 13.F.
  • – Credit from Banks, of the Company’s Financial Statements for the year ended December 31, 2022 (Ref No: 2023-02-022020).